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Bacillus coagulans is a ubiquitous soil bacterium that grows at 50-55 °C and pH 5.0 and fer-
ments various sugars that constitute plant biomass to L (+)-lactic acid. The ability of this spo-
rogenic lactic acid bacterium to grow at 50-55 °C and pH 5.0 makes this organism an attrac-
tive microbial biocatalyst for production of optically pure lactic acid at industrial scale not 
only from glucose derived from cellulose but also from xylose, a major constituent of hemi-
cellulose. This bacterium is also considered as a potential probiotic. Complete genome se-
quence of a representative strain, B. coagulans strain 36D1, is presented and discussed. 
Introduction 
In addition to its use in food and cosmetics, lactic 
acid is increasingly used as a starting material for 
production of bio-based, renewable plastics [1-3]. 
Optically pure lactic acid required by the bioplas-
tics industry is currently produced only by bacteri-
al fermentation of sugars [3,4]. The main sugars 
currently used in such fermentations are glucose 
derived from corn starch or sucrose from sugar 
cane, sugar beets, etc. With increasing demand for 
renewable bio-based plastics, there is a shift away 
from food-based carbohydrates to non-food carbo-
hydrates such as lignocellulosic biomass for lactic 
acid production [5,6]. Commercial fungal cellulases 
play a central role in the conversion of cellulose to 
glucose before fermentation to lactic acid and these 
enzymes function optimally at 50°C and pH 5.0 [7-
10]. By matching the fungal enzyme activity opti-
mum with that of the growth and fermentation op-
timum of the microbial biocatalyst, such as Bacillus 
coagulans, the amount of fungal cellulases required 
for simultaneous saccharification and fermentation 
(SSF) of cellulose to lactic acid can be reduced by a 
factor of three or higher compared to fermentation 
with lactic acid bacteria that grow optimally at 
temperatures below 40°C [9]. Since fungal enzymes 
represent a significant cost component of the over-
all process of biomass conversion to fuels and 
chemicals [11], reducing the enzyme loading dur-
ing SSF of cellulose to lactic acid by B. coagulans is 
expected to lower the overall process cost and help 
the bioplastics industry compete with petroleum-
based non-renewable plastics. 
Bacillus coagulans  belongs to a group of bacteria 
classified as sporogenic lactic acid bacteria [12]. 
These facultative anaerobes ferment pentoses, a 
component of hemicellulose, to L(+)-lactic acid as 
the major fermentation product reaching yields of 
90% and titers close to 100 g/L in about 48 hours 
[13,14]. In this regard, B. coagulans  differs from 
other lactic acid bacteria, such as Lactobacillus, Lac-
tococcus, etc., in its ability to ferment pentose su-
gars to lactic acid through the pentose-phosphate 
pathway in contrast to the phosphoketolase path-
way used by the lactic acid bacteria that yield an 
equimolar mixture of lactate and acetate [14]. Be-
cause of the thermotolerant, acid-tolerant and pen-
tose fermentation characteristics, there is signifi-
cant commercial interest in developing B. coagu-Bacillus coagulans strain 36D1 
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lans  as a microbial biocatalyst for production of 
optically pure lactic acid as well as other fuels and 
chemicals. The higher operating temperature of B. 
coagulans is also expected to significantly reduce 
contamination of industrial fermentations that 
could lower product quality [15]. 
B. coagulans  has been reported to function as a 
probiotic in animal trials and there is significant 
interest in the potential of this bacterium as a pro-
biotic in humans [16]. These studies suggest that B. 
coagulans can readily achieve the GRAS (generally 
regarded as safe) status required for large scale 
industrial use. Genetic tools are being developed 
for manipulating B. coagulans, a genetically recalci-
trant bacterium [17,18]. In order to fully explore 
the potential of B. coagulans as a microbial biocata-
lyst for production of fuels and chemicals, the en-
tire genome of B. coagulans  strain 36D1 was se-
quenced. Results from these experiments reveal 
that strain 36D1 has a single circular genome of 
3,552,226 base pairs that encode 3,306 protein 
coding regions. Other characteristics of this bacte-
rium, based on its genome composition, are pre-
sented and discussed. 
Classification and features 
B. coagulans was first isolated from coagulated milk 
by Hammer in 1915 [19]. Since then, several mem-
bers of this group have been isolated from various 
sources [12,14].  B. coagulans  strain 36D1 used in 
this study was isolated from a mud sample from an 
effluent stream of Old Faithful Geyser 1 near Calisto-
ga, California, USA as an organism that can grow on 
xylose at 50°C and pH 5.0 both aerobically and anae-
robically [14]. This bacterium is rod-shaped and 
produces endospore when cultured in nutrient 
broth (Fig. 1). Endospores are rarely observed when 
the bacterium was cultured in L-broth. Optimum 
temperature and pH for growth of strain 36D1 is 
55°C and 5.5, respectively [10]. Corn steep liquor at 
0.5% (w/v) provided the needed nutritional sup-
plements for growth in mineral salts medium and 
the growth rate of the bacterium in that medium at 
55°C was 1.67 h-1. The main fermentation product of 
the bacterium is L-lactate. Pentose fermentation in-
creases the level of acetate, ethanol and formate in 
the medium compared to hexose fermentation [14]. 
Anaerobic cultures started with sparging of the me-
dium with N2 require CO2 for growth. Other charac-
teristics of the bacterium are listed in Table 1. B. 
coagulans strain 36D1 is deposited in the American 
Type Culture Collection (PTA-5827). 
The  B. coagulans  group is polydisperse [12] and 
among the Bacillus spp., strain 36D1 is phylogenet-
ically close to B. halodurans  based on 16S 
rRNA(DNA) sequences (Fig. 2). Although B. coagu-
lans is similar to lactic acid bacteria in its ability to 
grow anaerobically and ferment sugars to lactic 
acid, it is distinct from the lactic acid bacteria based 
on 16S rRNA(DNA) sequence similarity. 
Genome sequencing and annotation 
Genome project history 
This genome was selected for sequencing on the 
basis of the properties described above. The ge-
nome sequence is deposited in GenBank (Accession 
number, CP003056). Sequencing was initiated and 
completed to a level of four contigs and annotated 
by the DOE Joint Genome Institute (JGI). The origi-
nal draft version was deposited in GenBank on Feb-
ruary 7, 2007 and the final draft version with four 
contigs was deposited on Feb. 3, 2010, thereby up-
dating previous releases to the database. Genome 
sequencing was completed at the University of 
Florida, annotated by the Oak Ridge National La-
boratory, and processed by the Los Alamos Nation-
al Laboratory and NCBI. A summary of the project 
information is shown in Table 2. 
Growth conditions and DNA isolation 
B. coagulans strain 36D1 was cultured in LB + glu-
cose (10 g/L) medium (pH 5.0) at 50°C in a shaker 
at 200 RPM as described before [10]. Cells were 
harvested during mid-exponential phase of growth. 
Cell pellet from a 30 ml culture was resuspended in 
2.1 ml of TE buffer (Tris, 10 mM; EDTA, 10 mM; pH 
8.0) supplemented with lysozyme (1 mg/ml; Sigma 
Chemical Co., St. Louis, MO, USA) and RNase (0.1 
mg/ml; Sigma Chemical Co.). The sample was incu-
bated at 37°C for 20 minutes to remove the cell 
wall. Sodium dodecyl sulfate (SDS) was added to 
the lysed cells to achieve an SDS concentration of 
1.4%. After 10 minutes on ice, the lysate was ex-
tracted with equal volume of TE-saturated phenol 
to remove cellular debris. After two more extrac-
tions of the aqueous phase with equal volumes of 
phenol-chloroform mixture (25:24:1 of phenol, 
chloroform and isoamyl alcohol), and one extrac-
tion with an equal volume of chloroform:isoamyl 
alcohol, the DNA was precipitated with ethanol and 
dried. The ratio of absorbance at 260 nm and 280 
nm of the purified DNA was 1.99 and based on aga-
rose gel electrophoresis and ethidium bromide 
staining, DNA contained only a trace amount of de-
graded RNA.  Rhee et al. 
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Figure 1. Thin section electron micrographs of B. coagulans strain 36D1. Left: vegetative 
cell. Upper right: sporulating cell. Lower right: mature spore. 
Genome sequencing and assembly 
The genome was sequenced using a combination of 
Sanger and 454 sequencing platforms. General as-
pects of library construction and sequencing can be 
found at the JGI website [32]. 454 pyrosequencing 
reads were assembled using the Newbler assemb-
ler version 1.1.02.15 (Roche). Large Newbler con-
tigs were broken into 2 kb overlapping fragments 
(1 kb overlap) and entered into assembly as pseu-
do-reads. The sequences were assigned quality 
scores based on Newbler consensus q-scores with 
modifications to account for overlap redundancy 
and to adjust inflated q-scores. A hybrid 
454/Sanger assembly was made using the Phrap 
assembler. Possible mis-assemblies were corrected 
with Dupfinisher or transposon bombing of bridg-
ing clones. Editing in Consed, custom primer walk 
or PCR amplification closed gaps between contigs. 
A total of 2,471 Sanger finishing reads were pro-
duced to close gaps, to resolve repetitive regions, 
and to raise the quality of the finished sequence. 
The error rate of the completed genome sequence 
was less than 1 in 100,000. Together all sequence 
types provided 9 x coverage of the genome. The 
final assembly contains a total of 35,357 Sanger 
and pyrosequence reads. This analysis yielded four 
contigs with lengths of 2,712, 65,471, 565,365 and 
2,917,758 base pairs for a total of 3,551,306 base 
pairs. 
In order to close the gaps, a restriction map of B. 
coagulans  strain 36D1 genome was constructed 
using BglII restriction enzyme. This optical map-
ping by OpGen (Gaithersburg, MD) yielded a circu-
lar map of approximately 3,521 kbp. Comparing 
the computed restriction map of the DNA se-
quence from the four contigs with the restriction 
map of the whole genome, the lengths of the gaps 
between the appropriate contigs were predicted. 
Using the sequence information from the contigs 
and appropriate restriction fragments, PCR pri-
mers were synthesized and the genomic DNA was 
sequenced using Sanger method by the Interdis-
ciplinary Center for Biotechnology Research at the 
University of Florida. As needed, PCR primers 
were synthesized based on new sequence infor-
mation for genome walking to fill-in the gaps and 
complete the genome sequence. Based on these 
analyses, the genome of B. coagulans strain 36D1 
was determined to be circular with a length of 
3,552,226 base pairs. Bacillus coagulans strain 36D1 
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Table 1. Classification and general features of Bacillus coagulans strain 36D1 
MIGS ID  Property  Term  Evidence code 
MIGS-2    Domain Bacteria  TAS [20] 
    Phylum Firmicutes  TAS [21-23] 
    Class Bacilli  TAS [24,25] 
  Classification  Order Bacillales  TAS [26,27] 
    Family Bacillaceae  TAS [26,28] 
    Genus Bacillus  TAS [26,29,30] 
MIGS-3    Species Bacillus coagulans  TAS [12,19,26] 
    Strain 36D1   
  Gram stain  Positive  IDA 
  Cell shape  Rods  IDA 
  Motility  Yes  IDA 
  Sporulation  Yes  IDA 
  Temperature range  Thermotolerant; 30 – 60 °C  TAS [10] 
  Optimum temperature  55 °C  TAS [10] 
MIGS-22  Oxygen requirement  Facultative anaerobe  TAS [14] 
 
Carbon source 
Glucose, xylose, arabinose, galactose, maltose,  
fructose, cellobiose, yeast extract, peptone 
IDA 
  Energy source  Organic carbon compounds  IDA 
  Terminal electron acceptor  O2, acetate, pyruvate  TAS [14] 
MIGS-6  Habitat  Soil  TAS [14] 
MIGS-15  Biotic relationship  Free-living  TAS [14] 
MIGS-14  Pathogenicity  None; potential probiotic  NAS 
  Biosafety level  1  NAS 
  Isolation  Soil  TAS [14] 
MIGS-4  Geographic location  Near Calistoga, California, USA  TAS [14] 
MIGS-5  Sample collection time  2000   IDA 
MIGS-4.1  Latitude  38.58 N  NAS 
MIGS-4.2  Longitude  -122.58  NAS 
MIGS-4.3  Depth  Surface  TAS [14] 
MIGS-4.4  Altitude  351’  NAS 
Evidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (i. e. a direct 
report exists in the literature); NAS: Non-traceable Author Statement (i. e. not directly observed for the living, isolated 
sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are 
from the Gene Ontology project [31]. If the evidence code is IDA, then the property was directly observed for a living 
isolate by one of the authors or an expert mentioned in the acknowledgements. 
 Rhee et al. 
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Figure 2. Unrooted phylogenetic tree based on 16S rRNA(DNA) of B. coagulans strain 36D1 and Bacil-
lus spp. and Lactobacillus spp. 
Genome annotation 
Genes were identified using Prodigal [33] as part 
of the Oak Ridge National Laboratory genome an-
notation pipeline. The predicted CDSs were trans-
lated and used to search the National Center for 
Biotechnology Information (NCBI) nonredundant 
database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, 
COG, and InterPro databases. These data sources 
were combined to assert a product description for 
each predicted protein. Non-coding genes and 
miscellaneous features were predicted using 
tRNAscan-SE [34], RNAMMer [35], Rfam [36], 
TMHMM [37], and signalP [38]. 
Genome properties 
The genome consists of a 3,552,226 bp long chro-
mosome with a 46.5% GC content (Figure 3 and 
Table 3). Of the 3,420 genes predicted, 3,306 were 
protein coding genes, and 114 encode RNAs. 
Among the 114 RNA genes, 10 each coded for 5S, 
16S and 23S rRNAs and 84 can be accounted for 
tRNAs. 
The  majority of the protein-coding genes (74%) 
were assigned with a putative function while 
those remaining were annotated as hypothetical 
proteins. About 49 ORFs were identified as poten-
tial transposases. The distribution of genes into 
COGs functional categories is presented in Table 4. 
The first about 40% of the genome is predomi-
nantly transcribed from the lagging strand (as 
written) while the other 60% is transcribed from 
the leading strand (Fig. 4). Bacillus coagulans strain 36D1 
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Table 2. Genome sequencing project information 
MIGS ID  Property  Term 
MIGS-31  Finishing quality  Finished 
MIGS-28  Libraries used 
Genomic libraries: Sanger (one each of 2.5, 8 and 37 kbp library); 
one 454CT library (2 kb); PCR; primer walk 
MIGS-29  Sequencing platforms  Sanger; 454 
MIGS-31.2  Sequencing coverage  9× 
MIGS-30  Assemblers  Phrap, Newbler 
MIGS-32  Gene calling method  Prodigal 
  Genome Database  GenBank 
  INSDC ID  CP003056 
  Genbank Date of Release  September 26, 2011 
  GOLD ID  GC01988 
  NCBI project ID  15679 
MIGS-13  Source material identifier  ATCC PTA-5827 
  Project relevance  Biotechnological 
 
Fig. 3. Graphical circular map of the genome of B. coagulans strain 36D1. From outside to center: 
Genes on forward strand (color by COG categories), Genes on reverse strand (color by COG cate-
gories), pseudogenes, % G+C, GC skew. Rhee et al. 
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Table 3. Genome statistics 
Attribute  Value  % of total 
Genome Size (bp)  3,552,226  100 
DNA G+C content (bp)  1,651,327  46.5 
Number of replicons  1   
Extrachromosomal elements  0   
Total genes  3420  100 
RNA genes  114  3.3 
Protein-coding genes  3306  96.7 
Genes in paralog clusters  541  15.6 
Genes assigned to COGs  2456  71.0 
Genes with signal peptides  858  24.8 
Genes with transmembrane helices  863  24.9 
Paralogous groups  199  5.8 
Insights from genome sequence 
Comparison of the predicted proteome of B. coa-
gulans  with that of a group of Bacillus  spp ge-
nomes identified 491 unique proteins in B. coa-
gulans that are not identified in other members 
of Bacillus spp. 404 of these genes are in the early 
part of the 36D1 genome as listed. This list in-
cludes 31 genes encoding putative transposases. 
Function of many of these gene products is not 
known. However, 413 of these unique proteins 
are found to be shared with Lactobacillus spp. In 
reverse, comparison of the B. coagulans genome 
with the genomes from a group of Lactobacillus 
spp. revealed that 423 ORFs are unique to B. coa-
gulans and of these, 345 ORFs, mostly related to 
sporulation, are shared with Bacillus spp. Com-
bining these two sets, a set of 78 ORFs coding for 
proteins with unknown function are unique to B. 
coagulans that are not present in either Bacillus 
or Lactobacillus. Based on principal components 
analysis,  B. coagulans  strain 36D1 groups with 
Bacillus but as an outlier and away from Lactic 
acid bacteria (Fig. 4). Although B. coagulans pro-
duced L-lactic acid as the fermentation product at 
an optical purity reaching close to 100%, the ge-
nome contains a gene encoding D-LDH. 
Although some members of B. coagulans  group 
are cellulolytic and xylanolytic, strain 36D1 is 
phenotypically unable to utilize cellulose and xy-
lan. However, genes encoding glycan hydrolases 
such as xylanase, xylosidase and α-amylase can 
be identified in the genome sequence. Presence 
of these genes suggest that the bacterium can be 
evolved to produce xylanase to reduce the severi-
ty of acid treatment during hydrolysis of hemicel-
lulose from lignocellulosic biomass for produc-
tion of optically pure lactic acid. B. coagulans 
strain 36D1 is an auxotroph for several amino 
acids and vitamins. Based on analysis of the ge-
nome sequence by Patric Comparative pathway 
tool [39], only histidine biosynthetic pathway 
appears to be incomplete among the amino acid 
biosynthesis pathways. Among the vitamins, the 
pathways for biosynthesis of biotin, pantothenic 
acid, nicotinamide and pyridoxine appear to be 
incomplete. 
During the time of preparation of this manuscript, 
genome sequence for B. coagulans strain 2-6 was 
published [40]. The genome of this strain is 
3,073,079 and is 479,147 bp smaller than the ge-
nome of strain 36D1. These two B. coagulans ge-
nomes share about 90% or higher nucleotide se-
quence identity in the regions that are present in 
both genomes. Additional comparative analysis 
of the two genomes is in progress. Bacillus coagulans strain 36D1 
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Table 4. Number of genes associated with the general COG functional groups 
Code  Value  %age  Description 
J  172  5.14  Translation 
A  0  0.00  RNA processing and modification 
K  238  7.11  Transcription 
L  144  4.30  Replication, recombination and repair 
B  2  0.05  Chromatin structure and dynamics 
D  106  3.16  Cell cycle control, mitosis and meiosis 
Y  0  0.00  Nuclear structure 
V  113  3.37  Defense mechanisms 
T  162  4.84  Signal transduction mechanisms 
M  240  7.17  Cell wall/membrane biogenesis 
N  78  2.33  Cell motility 
Z  0  0.00  Cytoskeleton 
W  0  0.00  Extracellular structures 
U  50  1.49  Intracellular trafficking and secretion 
O  182  5.44  Posttranslational modification, protein turnover, chaperones 
C  277  8.28  Energy production and conversion 
G  310  9.26  Carbohydrate transport and metabolism 
E  379  11.33  Amino acid transport and metabolism 
F  100  2.98  Nucleotide transport and metabolism 
H  217  6.48  Coenzyme transport and metabolism 
I  104  3.10  Lipid transport and metabolism 
P  214  6.39  Inorganic ion transport and metabolism 
Q  168  5.02  Secondary metabolites biosynthesis, transport and catabolism 
R  448  13.39  General function prediction only 
S  242  7.23  Function unknown 
-      Not in COGs (Total – 3345) 
 
Figure. 4. Principal component analysis based on COG profiles Rhee et al. 
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